Metrics Inc. offers Cleantaste technology, which enables polymer coating of individual drug crystals to produce particles sized 25 um to 125 um.
Metrics Inc. offers Cleantaste technology, which enables polymer coating of individual drug crystals to produce fine, non-gritty particles sized 25 um to 125 um. This technology can improve the taste and mouth-feel of drugs and can be used to support stability or deliver sustained release characteristics, the company reports. Cleantaste technology is suitable for orally dispersible tablets and encapsulated products, the company reports.
Metrics’ areas of expertise include quality pharmaceutical formulation development; first-time-in-man (FTIM) formulations; clinical trial manufacturing (CTM) for Phase I, II and III trials; and analytical method development and validation services leading to commercial scale manufacturing.
